Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?
Geneva; World Health Organization; 2013. (WHO/HIV/2013.21).
in En
| WHOLIS
| ID: who-90573
Responsible library:
CH1.1
Subject(s)
Full text:
1
Collection:
04-international_org
Database:
WHOLIS
Main subject:
Tuberculosis
/
HIV Infections
/
Anti-Retroviral Agents
Language:
En
Year:
2013